ATE459599T1 - PURIFIED LASOFOXIFEN AND METHOD FOR PURIFYING RACEMIC LASOFOXIFEN BY RECRYSTALLIZATION - Google Patents
PURIFIED LASOFOXIFEN AND METHOD FOR PURIFYING RACEMIC LASOFOXIFEN BY RECRYSTALLIZATIONInfo
- Publication number
- ATE459599T1 ATE459599T1 AT03745203T AT03745203T ATE459599T1 AT E459599 T1 ATE459599 T1 AT E459599T1 AT 03745203 T AT03745203 T AT 03745203T AT 03745203 T AT03745203 T AT 03745203T AT E459599 T1 ATE459599 T1 AT E459599T1
- Authority
- AT
- Austria
- Prior art keywords
- lasofoxifen
- recrystallization
- purified
- purifying racemic
- racemic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36887202P | 2002-03-28 | 2002-03-28 | |
| PCT/IB2003/001033 WO2003082814A1 (en) | 2002-03-28 | 2003-03-17 | Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE459599T1 true ATE459599T1 (en) | 2010-03-15 |
Family
ID=28675551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03745203T ATE459599T1 (en) | 2002-03-28 | 2003-03-17 | PURIFIED LASOFOXIFEN AND METHOD FOR PURIFYING RACEMIC LASOFOXIFEN BY RECRYSTALLIZATION |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6906202B2 (en) |
| EP (1) | EP1487790B1 (en) |
| JP (1) | JP4268055B2 (en) |
| KR (1) | KR100636953B1 (en) |
| CN (1) | CN1283625C (en) |
| AR (1) | AR039152A1 (en) |
| AT (1) | ATE459599T1 (en) |
| AU (1) | AU2003209603B2 (en) |
| BR (1) | BR0308758A (en) |
| CA (1) | CA2479924C (en) |
| DE (1) | DE60331527D1 (en) |
| DK (1) | DK1487790T3 (en) |
| ES (1) | ES2339936T3 (en) |
| HK (1) | HK1073111A1 (en) |
| HU (1) | HUP0500025A3 (en) |
| IL (2) | IL162929A0 (en) |
| MX (1) | MXPA04009259A (en) |
| PL (1) | PL372727A1 (en) |
| RS (1) | RS80604A (en) |
| RU (1) | RU2278861C2 (en) |
| TW (1) | TW200306974A (en) |
| WO (1) | WO2003082814A1 (en) |
| ZA (1) | ZA200405209B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL162929A0 (en) * | 2002-03-28 | 2005-11-20 | Pfizer Prod Inc | Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| WO2007095161A2 (en) * | 2006-02-14 | 2007-08-23 | New York University | Methods and compositions for treating disorders associated with increased bone turnover and osteopenia |
| CZ2007373A3 (en) * | 2007-05-29 | 2008-12-10 | Zentiva, A. S | Process for preparing lasofoxifene |
| CN102311406A (en) * | 2010-06-29 | 2012-01-11 | 武汉启瑞药业有限公司 | Method for preparing lasofoxifene intermediate |
| SG11201903236SA (en) | 2016-10-11 | 2019-05-30 | Univ Duke | Lasofoxifene treatment of er+ breast cancer |
| WO2019199891A1 (en) | 2018-04-10 | 2019-10-17 | Duke University | Lasofoxifene treatment of breast cancer |
| KR102412089B1 (en) | 2021-09-13 | 2022-06-22 | 주식회사 세라수 | A method for refining DMTS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5326865A (en) * | 1990-06-08 | 1994-07-05 | Hercules Incorporated | Arylazo and poly(arylazo) dyes having at least one core radical selected from naphthyl or anthracyl and having at least one 2,3-dihydro-1,3-dialkyl perimidine substituent |
| US5552412A (en) * | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
| EP0756205A3 (en) * | 1995-07-26 | 1998-10-14 | Eastman Kodak Company | Pattern transfer techniques for fabrication of lenslet arrays using specialized polyesters |
| UA51676C2 (en) | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition |
| YU26700A (en) * | 1999-05-24 | 2002-06-19 | Pfizer Products Inc. | Process for cis -1-(2-(4-(6-metoxy-2-pheniyl-1,2,3,4-tetrahydronaphtalen-1-yl)phenoksy)etil)pyrrolidine |
| US6180375B1 (en) * | 1999-08-27 | 2001-01-30 | Pfizer Inc. | Microbial biotransformation |
| WO2002087546A2 (en) | 2001-05-01 | 2002-11-07 | Pfizer Products Inc. | Method for manufacturing a low dose pharmaceutical composition |
| IL162929A0 (en) * | 2002-03-28 | 2005-11-20 | Pfizer Prod Inc | Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
-
2003
- 2003-03-17 IL IL16292903A patent/IL162929A0/en unknown
- 2003-03-17 RU RU2004128931/04A patent/RU2278861C2/en not_active IP Right Cessation
- 2003-03-17 WO PCT/IB2003/001033 patent/WO2003082814A1/en not_active Application Discontinuation
- 2003-03-17 RS YUP-806/04A patent/RS80604A/en unknown
- 2003-03-17 PL PL03372727A patent/PL372727A1/en not_active Application Discontinuation
- 2003-03-17 EP EP03745203A patent/EP1487790B1/en not_active Expired - Lifetime
- 2003-03-17 ES ES03745203T patent/ES2339936T3/en not_active Expired - Lifetime
- 2003-03-17 AT AT03745203T patent/ATE459599T1/en not_active IP Right Cessation
- 2003-03-17 AU AU2003209603A patent/AU2003209603B2/en not_active Ceased
- 2003-03-17 MX MXPA04009259A patent/MXPA04009259A/en active IP Right Grant
- 2003-03-17 BR BR0308758-1A patent/BR0308758A/en not_active IP Right Cessation
- 2003-03-17 DE DE60331527T patent/DE60331527D1/en not_active Expired - Lifetime
- 2003-03-17 KR KR1020047015249A patent/KR100636953B1/en active IP Right Grant
- 2003-03-17 CN CNB038031175A patent/CN1283625C/en not_active Expired - Lifetime
- 2003-03-17 DK DK03745203.4T patent/DK1487790T3/en active
- 2003-03-17 CA CA002479924A patent/CA2479924C/en not_active Expired - Fee Related
- 2003-03-17 JP JP2003580282A patent/JP4268055B2/en not_active Expired - Fee Related
- 2003-03-17 HU HU0500025A patent/HUP0500025A3/en unknown
- 2003-03-26 AR ARP030101058A patent/AR039152A1/en unknown
- 2003-03-26 US US10/397,654 patent/US6906202B2/en not_active Expired - Lifetime
- 2003-03-27 TW TW092106928A patent/TW200306974A/en unknown
-
2004
- 2004-06-30 ZA ZA2004/05209A patent/ZA200405209B/en unknown
- 2004-07-08 IL IL162929A patent/IL162929A/en active IP Right Grant
-
2005
- 2005-03-28 US US11/092,240 patent/US7358374B2/en active Active
- 2005-07-11 HK HK05105808A patent/HK1073111A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE540962T1 (en) | EXTRACTIVE PROCESS FOR THE PURIFICATION OF SUCRALOSE | |
| ATE369201T1 (en) | METHOD FOR PURIFYING SYNTHESIS GAS | |
| DE60302319D1 (en) | System and method for purifying water | |
| DE60218418D1 (en) | System and method for driving assistance | |
| ATE500824T1 (en) | METHOD FOR PURIFYING TRANS-(-)-DELTA9-TETRAHYDROCANNABINOL AND TRANS-(+)-DELTA9-TETRAHYDROCANNABINOL | |
| ATE316092T1 (en) | METHOD FOR IMPROVING THE PURITY AND YIELD OF SUCRALOSE | |
| DE60329876D1 (en) | Method and system for improving driver assistance | |
| DE60331482D1 (en) | System and method for optimizing graphics processing by polygonal division | |
| DE60321938D1 (en) | COMPOSITION FOR SLIME PREVENTION AND PROCESS FOR SLIME PREVENTION | |
| ATE394369T1 (en) | METHOD FOR PURIFYING MESOTRION | |
| DE60327356D1 (en) | METHOD FOR SYNTHESIS OF METAL NANOTEILES | |
| DE50312128D1 (en) | Steering and steering method | |
| ATE336464T1 (en) | METHOD FOR PURIFYING HYDROGEN ACID | |
| ATE459599T1 (en) | PURIFIED LASOFOXIFEN AND METHOD FOR PURIFYING RACEMIC LASOFOXIFEN BY RECRYSTALLIZATION | |
| DE50303611D1 (en) | METHOD FOR PRODUCING POLYISOBUTES | |
| DE50300917D1 (en) | Plant component and method for the decomposition and purification of syngas | |
| ATE439356T1 (en) | METHOD FOR PRODUCING CHIRAL N-ARYL PIPERAZINES | |
| ATE387367T1 (en) | METHOD AND SYSTEM FOR SUPPORTING THE OPERATION OF WORK TRAINS | |
| ATE402138T1 (en) | METHOD FOR PRODUCING 2-AMINOINDANDERIVATES | |
| DE60324272D1 (en) | METHOD FOR COOLING STEEL PLATE AND METHOD FOR PRODUCING STEEL PLATE | |
| DE60315255D1 (en) | COMPOSITION AND METHOD FOR COMBATING TERMITES | |
| ATE326428T1 (en) | METHOD AND PLANT FOR DESALING SALTWATER | |
| DE60328693D1 (en) | METHOD FOR OXADIMATING CARBONYL COMPOUNDS | |
| DE60311187D1 (en) | Data output driver and data output method for minimizing data output timing deviations caused by data patterns | |
| ATE322478T1 (en) | METHOD FOR PURIFYING CAPROLACTAM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |